Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome
This exploratory open-label, randomized study examined the effects of acetylcarnitine and propionylcarnitine on fatigue and attention concentration in patients with chronic fatigue syndrome (CFS). Acetylcarnitine significantly improved mental fatigue (p = 0.015), while propionylcarnitine improved general fatigue (p = 0.004), with both treatments enhancing attention concentration. However, combined treatment was
June 26, 2025
No Comments